Chattanooga Medical Research, LLC   Report issue

For profit Phase 3
Founded: Chattanooga TN United States (2007)

Organization Overview

First Clinical Trial
2008
NCT00786188
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Chattanooga Medical Research, LLC, Chattanooga, TN 37404

Active Ingredients

Drugs in Phase 3 Trials (1)

paroxetine (paxil) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hot Flashes (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1